Firms
Theme

CRAI

CRA International, Inc. · NASDAQ

News

2 latest

Zacks Investment Research

Booz Allen Hamilton (BAH) Q2 Earnings Beat Estimates

Booz Allen Hamilton reported Q3 2026 earnings of $1.76 per share, beating consensus estimates of $1.44 by 22.22%, though revenues of $2.78 billion missed expectations by 0.81%. The stock has underperformed the S&P 500 by 6.9% year-to-date but holds a Zacks Rank #2 (Buy) rating based on favorable estimate revisions. CRA International is expected to report results on November 5 with projected earnings of $2.06 per share and revenues of $198.64 million.

Zacks Investment Research

CRAI Stock Rises 12.4% in Three Months: Here's What You Should Know

Charles River Associates (CRAI) shares jumped 12.4% over three months, outperforming its industry. The company reported broad-based revenue growth across all service lines and geographies, with operating income up 19.3% year-over-year. CRAI raised its fiscal 2026 constant-currency revenue guidance to $805-$820 million and returned $31.4 million to shareholders in Q2 through repurchases and dividends.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CRAI · 0 threads

Sign in to post on $CRAI

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev